Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CAP-100
i
Other names:
CAP-100, CAP 100
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Catapult Therap
Drug class:
CCR7 receptor antagonist
‹
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
CCR7 expresion
Chronic Lymphocytic Leukemia
CCR7 expresion
Chronic Lymphocytic Leukemia
CAP-100
Sensitive: C3 – Early Trials
CAP-100
Sensitive
:
C3
CAP-100
Sensitive: C3 – Early Trials
CAP-100
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.